(Health-NewsWire.Net, November 03, 2016 ) -A review of the Prezista based on information derived from company and industry-specific sources -Coverage of the Marketed data of the Prezista on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification -Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Prezista with location details -Patent Expiry Timeline and Exclusivity Details -Route of Synthesis of the API -Global Forecasted Sales Figure to 2018 -Qualitative and quantitative assessment of market space -SWOT Analysis
Reasons to buy
-Evaluate the marketing status and exclusivity details of Prezista to exploit opportunities for generic drug development opportunities. -Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Prezista. -API intelligence over Prezista and gaining primary intelligence over Active Ingredients manufacturers across the globe. -Understanding the chemical route of synthesis of Prezista. -Uncovering opportunities in the rapidly growing the US market -Stay ahead of competition by understanding the changing competitive landscape -Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential -Make more informed business decisions from insightful and in-depth analysis of the drug's performance -Obtain sales forecast for currently marketed drug for to 2018
1. DelveInsight Report Introduction 2. Prezista Overview 2.1 Market Competition 2.3 Competitors in Development 3 Global Sales Assessment 3.1 Historical Sales of Prezista 3.2 Forecasted Sales of Prezista 4 Product Description 4.1 Mechanism of Action 4.2 Pharmacodynamic Properties 4.3 Pharmacokinetic Properties 5 Marketed Details 5.1 United States 5.2 Europe 6 Patent Information 6.1 Patent Numbers and Expiry Details 6.2 Patent and Exclusivity Expiry Assessment United States (US) 6.3 Patent Details 7 Route of Synthesis 8 Global API Manufacturers Assessment 8.1 The United States Drug Master File (US DMF) 8.2 The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF) 8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China 8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India 9 Generic Players 10 The Pipeline Coverage 11 Clinical Trials Information